Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2014, Article ID 697675, 7 pages
http://dx.doi.org/10.1155/2014/697675
Research Article

Outcome of Adolescents with Acute Lymphoblastic Leukemia Treated by Pediatrics versus Adults Protocols

1Department of Medical Oncology and Hematological Malignancy, South Egypt Cancer Institute, Assiut University, El Methaq Street, Assiut, Egypt
2Department of Pediatrics Oncology and Hematological Malignancy, South Egypt Cancer Institute, Assiut University, Egypt

Received 10 August 2014; Revised 22 October 2014; Accepted 29 October 2014; Published 17 November 2014

Academic Editor: Myriam Labopin

Copyright © 2014 Abeer Ibrahim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C.-H. Pui, L. L. Robison, and A. T. Look, “Acute lymphoblastic leukaemia,” The Lancet, vol. 371, no. 9617, pp. 1030–1043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-H. Pui, C. G. Mullighan, W. E. Evans, and M. V. Relling, “Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?” Blood, vol. 120, no. 6, pp. 1165–1174, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Freireich, “The history of leukemia therapy—a personal journey,” Clinical Lymphoma Myeloma and Leukemia, vol. 12, no. 6, pp. 386–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-H. Pui, D. Campana, D. Pei et al., “Treating childhood acute lymphoblastic leukemia without cranial irradiation,” The New England Journal of Medicine, vol. 360, no. 26, pp. 2730–2741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. I. Sive, G. Buck, A. Fielding et al., “Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial,” British Journal of Haematology, vol. 157, no. 4, pp. 463–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Thomas, S. O'Brien, S. Faderl et al., “Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome—negative precursor B-lineage acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 28, no. 24, pp. 3880–3889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-H. Pui and W. E. Evans, “Treatment of acute lymphoblastic leukemia,” The New England Journal of Medicine, vol. 354, no. 2, pp. 166–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Stock, H. Satjer, R. K. Dodge, C. D. Bloomfield, R. A. Larson, and J. Nachman, “Outcome of adolescents and young adults with ALL: a comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) regimens,” Blood, vol. 96, abstract 476, 2000. View at Google Scholar
  9. N. Boissel, M.-F. Auclerc, V. Lhéritier et al., “Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials,” Journal of Clinical Oncology, vol. 21, no. 5, pp. 774–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. de Bont, B. van der Holt, A. W. Dekker, A. van der Does-van den Berg, R. Sonneveld, and R. Pieters, “Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands,” Leukemia, vol. 18, no. 12, pp. 2032–2035, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Ramanujachar, S. Richards, I. Hann, and D. Webb, “Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols,” Pediatric Blood and Cancer, vol. 47, no. 6, pp. 748–756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Ramanujachar, S. Richards, I. Hann et al., “Adolescents with acute lymphoblastic leukaemia: outcome on UK National Paediatric (ALL97) and adult (UKALLXII/E2993) trials,” Pediatric Blood & Cancer, vol. 48, no. 3, pp. 254–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Schrøder, M. Kjeldahl, A. M. Boesen et al., “Acute lymphoblastic leukemia in adolescents between10 and 19 years of age in Denmark,” Danish Medical Bulletin, vol. 53, no. 1, pp. 76–79, 2006. View at Google Scholar
  14. A. M. Testi, M. G. Valsecchi, V. Conter et al., “Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols,” Blood, vol. 104, p. 1954, 2004. View at Google Scholar
  15. H. Hallböök, G. Gustafsson, B. Smedmyr, S. Söderhäll, and M. Heyman, “Treatment outcome in young adults and children > 10 year of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol,” Cancer, vol. 107, no. 7, pp. 1551–1561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. A. Schiffer, “Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both?” Journal of Clinical Oncology, vol. 21, no. 5, pp. 760–761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. De Angelo, “The treatment of adolescents and young adults with acute lymphoblastic leukemia,” Hematology/the Education Program of the American Society of Hematology, pp. 123–130, 2005. View at Google Scholar
  18. S. E. Sallan, “Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia,” Hematology/the Education Program of the American Society of Hematology: American Society of Hematology, vol. 2006, no. 1, pp. 128–132, 2006. View at Google Scholar · View at Scopus
  19. D. J. DeAngelo, L. B. Silverman, S. Couban et al., “A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphoblastic leukaemia,” Blood, vol. 108, p. 526a, 2006. View at Google Scholar
  20. F. Huguet, T. Leguay, E. Raffoux et al., “Pediatric-inspired therapy in adults with philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study,” Journal of Clinical Oncology, vol. 27, no. 6, pp. 911–918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. L. Kaplan and P. Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, pp. 457–481, 1958. View at Publisher · View at Google Scholar · View at MathSciNet
  22. W. Stock, M. La, B. Sanford et al., “What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies,” Blood, vol. 112, no. 5, pp. 1646–1654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Boissel, M.-F. Auclerc, V. Lhéritier et al., “Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials,” Journal of Clinical Oncology, vol. 21, no. 5, pp. 774–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Ramanujachar, S. Richards, I. Hann et al., “Adolescents with acute lymphoblastic leukaemia: outcome on UK National Paediatric (ALL97) and adult (UKALLXII/E2993) trials,” Pediatric Blood and Cancer, vol. 48, no. 3, pp. 254–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Usvasalo, R. Räty, S. Knuutila et al., “Acute lymphoblastic leukemia in adolescents and young adults in Finland,” Haematologica, vol. 93, no. 8, pp. 1161–1168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. L. B. Silverman, R. D. Gelber, V. K. Dalton et al., “Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01,” Blood, vol. 97, no. 5, pp. 1211–1218, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Riehm, H. Gadner, G. Henze et al., “Results and significance of six randomized trials in four consecutive ALL-BFM studies,” Haematology and Blood Transfusion, vol. 33, pp. 439–450, 1990. View at Google Scholar · View at Scopus
  28. J. B. Nachman, H. N. Sather, M. G. Sensel et al., “Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy,” The New England Journal of Medicine, vol. 338, no. 23, pp. 1663–1671, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-M. Ribera, A. Oriol, M.-A. Sanz et al., “Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the programa Español de tratamiento en hematología pediatric-based protocol ALL-96,” Journal of Clinical Oncology, vol. 26, no. 11, pp. 1843–1849, 2008. View at Publisher · View at Google Scholar · View at Scopus